Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.

K Kanthakumar, D R Cundell, M Johnson, P J Wills, G W Taylor, P J Cole, R Wilson
Author Information
  1. K Kanthakumar: Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London.

Abstract

1. Patients with airway infection by Pseudomonas aeruginosa have impaired mucociliary clearance. Pyocyanin is a phenazine pigment produced by P. aeruginosa which is present in the sputum of colonized patients, slows human ciliary beat frequency (CBF) in vitro and slows mucociliary transport in vivo in the guinea-pig. 2. We have investigated the effect of salmeterol, a long-acting beta 2-adrenoceptor agonist, on pyocyanin-induced slowing of human CBF in vitro. Salmeterol (2 x 10(-7) M) was found to reduce pyocycanin (20 micrograms ml-1)-induced slowing of CBF by 53% and the fall in intracellular adenosine 3':5'-cyclic monophosphate (cyclic AMP) by 26% and ATP by 29%. 3. Another beta 2-adrenoceptor agonist, isoprenaline (2 x 10(-7) M), also inhibited pyocyanin-induced slowing of CBF by 39%. 4. The effects of salmeterol (30 min preincubation) persisted after washing the cells. 5. Propranolol (10(-7) M) and the beta 2-specific antagonist, ICI 118551 (10(-6) M) blocked the protective effects of salmeterol completely, but atenolol (10(-6) M) was less effective. These results suggested that the effects of salmeterol on pyocyanin-induced effects were mediated primarily via the stimulation of beta 2-adrenoceptors. 6. Pyocyanin-induced ciliary slowing is associated with a substantial fall in intracellular cyclic AMP and ATP. Salmeterol reversed the effects of pyocyanin on cyclic AMP and ATP. 7. Mucociliary clearance is an important defence mechanism of the airways against bacterial infection. Salmeterol may benefit patients colonized by P. aeruginosa, not only by its bronchodilator action, but also by protecting epithelial cells from pyocyanin-induced slowing of CBF.

References

  1. Arch Dis Child. 1976 Jan;51(1):28-33 [PMID: 942226]
  2. Br J Exp Pathol. 1953 Dec;34(6):583-7 [PMID: 13115587]
  3. Naunyn Schmiedebergs Arch Pharmacol. 1979 Sep;308(3):183-90 [PMID: 41190]
  4. Lancet. 1980 Sep 13;2(8194):564-5 [PMID: 6106741]
  5. J Appl Physiol Respir Environ Exerc Physiol. 1980 May;48(5):868-71 [PMID: 7451296]
  6. J Auton Pharmacol. 1981 Sep;1(4):305-12 [PMID: 6121816]
  7. J Clin Invest. 1987 Jan;79(1):221-9 [PMID: 3098783]
  8. J Immunol. 1987 May 15;138(10):3481-7 [PMID: 2952718]
  9. Clin Sci (Lond). 1988 Aug;75(2):113-20 [PMID: 3044667]
  10. Infect Immun. 1988 Sep;56(9):2515-7 [PMID: 3137173]
  11. J Appl Physiol (1985). 1988 Oct;65(4):1895-901 [PMID: 2846499]
  12. Br J Pharmacol. 1988 Sep;95(1):55-66 [PMID: 2851354]
  13. J Pharmacol Methods. 1989 Mar;21(1):71-86 [PMID: 2704248]
  14. Chest. 1989 Jul;96(1):158-64 [PMID: 2500307]
  15. J Appl Physiol (1985). 1989 Jul;67(1):316-23 [PMID: 2759959]
  16. Comp Biochem Physiol A Comp Physiol. 1989;94(2):351-7 [PMID: 2573479]
  17. Annu Rev Physiol. 1990;52:137-55 [PMID: 2184754]
  18. J Infect Dis. 1990 Jul;162(1):178-85 [PMID: 2162367]
  19. Lung. 1990;168 Suppl:115-9 [PMID: 1974668]
  20. Eur Respir J. 1991 Jul;4(7):789-95 [PMID: 1659538]
  21. Br J Pharmacol. 1991 Nov;104(3):665-71 [PMID: 1686740]
  22. J Appl Physiol (1985). 1992 Jun;72(6):2271-7 [PMID: 1629083]
  23. Am J Physiol. 1992 Aug;263(2 Pt 1):L232-42 [PMID: 1325130]
  24. Pulm Pharmacol. 1992 Dec;5(4):257-63 [PMID: 1362105]
  25. Br J Pharmacol. 1993 Feb;108(2):507-15 [PMID: 8095419]
  26. Infect Immun. 1993 Jul;61(7):2848-53 [PMID: 8390405]
  27. J Biol Chem. 1951 Nov;193(1):265-75 [PMID: 14907713]
  28. Anal Biochem. 1979 May;95(1):19-23 [PMID: 115327]

MeSH Term

Adenosine Triphosphate
Adrenergic beta-Agonists
Adrenergic beta-Antagonists
Albuterol
Bronchodilator Agents
Cells, Cultured
Cyclic AMP
Epithelial Cells
Epithelium
Humans
Isoproterenol
Mucociliary Clearance
Nasal Mucosa
Pseudomonas aeruginosa
Pyocyanine
Receptors, Adrenergic, beta-2
Salmeterol Xinafoate

Chemicals

Adrenergic beta-Agonists
Adrenergic beta-Antagonists
Bronchodilator Agents
Receptors, Adrenergic, beta-2
Salmeterol Xinafoate
Adenosine Triphosphate
Pyocyanine
Cyclic AMP
Isoproterenol
Albuterol

Word Cloud

Created with Highcharts 10.0.0CBFsalmeterolslowing10Meffectsbetapyocyanin-inducedaeruginosahumanciliary2Salmeterol-7cyclicAMPATPinfectionmucociliaryclearancePcolonizedpatientsslowsvitro2-adrenoceptoragonistxfallintracellularalsocells-6pyocyaninepithelial1PatientsairwayPseudomonasimpairedPyocyaninphenazinepigmentproducedpresentsputumbeatfrequencytransportvivoguinea-piginvestigatedeffectlong-actingfoundreducepyocycanin20microgramsml-1-induced53%adenosine3':5'-cyclicmonophosphate26%29%3Anotherisoprenalineinhibited39%430minpreincubationpersistedwashing5Propranolol2-specificantagonistICI118551blockedprotectivecompletelyatenolollesseffectiveresultssuggestedmediatedprimarilyviastimulation2-adrenoceptors6Pyocyanin-inducedassociatedsubstantialreversed7MucociliaryimportantdefencemechanismairwaysbacterialmaybenefitbronchodilatoractionprotectingEffectnasalcellbeating:inhibitionciliotoxin

Similar Articles

Cited By